Sunitinib in Sarcomas of the Central Nervous System

Clinical trial NCT03641326 · TERMINATED

Trial details

NCT number: NCT03641326
Sponsor: National Cancer Institute (NCI)
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Gliosarcoma Central Nervous System Sarcoma

Start date: 2019-02-21
Primary completion: 2021-04-02
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.